Traditional Chinese medicine for treating BPH combined overactive bladder syndrome

Abstract

The invention belongs to the technical field of medicine, and particularly relates to traditional Chinese medicine for treating a BPH combined overactive bladder syndrome. The traditional Chinese medicine is prepared from, by weight, 4-8 parts of gentiana sarcorrhiza ling et ma, 4-8 parts of ficus erecta roots, 4-8 parts of leaf of manynerve bauhinia, 4-8 parts of cluster mallow, 4-8 parts of rhizome of david woodbetony, 4-8 parts of herminium monorchis, 4-8 parts of fruits of fiverleaf akebia, 4-8 parts of leaves of delavey greenleaf elaeagnus, 4-8 parts of bigbract bulbophyllum, 4-8 parts of stems of obheartleaf, 4-8 parts of polypodium vulgare and 4-8 parts of tips of licorice roots. The medicines are combined, and the effects of invigorating the spleen, supplementing Qi, enriching Yin, nourishing the kidney and eliminating dampness and heat are achieved.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine for treating BPH complicated with overactive bladder. Background technique [0002] Overactive bladder is a syndrome characterized by symptoms of urinary urgency, often accompanied by frequency and nocturia, with or without urge incontinence; urodynamically it can manifest as detrusor overactivity or For other forms of urethro-bladder dysfunction. [0003] Benign prostatic hyperplasia (benign prostatic hyperplasia, BPH) is one of the most common urinary diseases in men over 40 years old, and the incidence of pathological benign prostatic hyperplasia in men over 80 years old is over 90%. The most basic pathological changes are bladder outlet obstruction and bladder detrusor function changes. Among them, detrusor instability (detrttsorinstability, DI) secondary to BPH can cause overactive bladder (OAB) such as urinary frequency and urge...

AI Technical Summary

Problems solved by technology

However, there are many adverse reactions, such as recurrence after drug withdrawal, such as dry mouth and other adverse reactions, the incidence rate is more than 20%.